Language: ENG | RUS | CHN



REVOFIL is the very first kind, the most revolutionary dermal filler as ideal solution for aged skin and remarkably designed for remodeling faces.

The Benefits

The cutting edge bio-technology
REVOFIL has both biphasic and monophasic physical characteristics introduced by combination of cutting edged biomimetic peptide technology and crossed linked HA which bring upgraded quality in gel viscosity and elasticity with softer operation.
REVOFIL contains higher concentration of free hyaluronic acid, linked with peptides, instead of PBS among cross-linked HA molecules which results in increased stability of HA gel Which is a safe material with natural compounds.

Long lasting, incomparable long duration: at least 10 ~ 12 months.
Strong inhibition of endogenous Hyaluronidase, increases duration of the gel in tissue.
REVOFIL makes up-regulation of endogenous collagen and hyaluronic acid to increase skin tightness and lifting. In overall, biomimetic peptide technology has endowed higher viscosity and elasticity, increased efficacy of sculpturing with longer lasting, increased gel stability and softer injection of hyaluronic acid gel.

Extraordinary firming and anti-wrinkle effect with natural looking
It involves an uncomplicated injection treatment with minimal scarring. With innovative active ingredients, REVOFIL makes you look natural and attractive by improving wrinkles.

The most Safe-dermal HA filler with peptides and highly qualified product
in the current market

High quality of hyaluronic acid and biomimetic peptides are safe with no-adverse effect and are biodegradable in the body.
This makes feel secure with a non-surgical and less invasive shaping and enhancement.

Immediate Results with a tailor-made aesthetic treatment
proved by thorough clinical study.

See the tab in this website "BEFORE & AFTER". In addition it makes return quickly to daily activities with a short post-treatment recovery period.

Based on the noticeable functional Peptides, REVOFIL has shown positive regulation of endogenous collagen and hyaluronic acid synthesis in human fibroblasts and strong resistance to the enzyme which implies its longer lasting in tissue.

In-vitro data of REVOFIL Fine, Plus, Ultra

Dermal / Epidermal Cohesive Effect : Increased 81% Collagen 1, 45% Hyaluronic acid

REVOFIL has shown positive regulation of endogenous collagen and hyaluronic acid synthesis in human fibroblast cell.

Direct Inhibition of Hyaluronidase Activity : Decreased 90% Hyaluronidase Activity

REVOFIL contains a strong inhibitor of hyaluronidase. REVORIL, binds to the enzyme strongly and down-regulates the degradation of reticulated hyaluronic acid which implies increased duration of the gel in skin.

Protection of Anti-oxidative stress and Photo-induced Cell Damage

REVOFIL shows strong anti-oxidant effect against oxidative chemical and photo-damage induced UV in human dermal fibroblasts.

Decreased Enzymatic Degradation

REVOFIL showed strong resistance to the enzyme which implies longer lasting in skin compared to competitors. The result indicates that the duration of REVOFIL is much longer than other HA Dermal fillers.

In-vitro data of REVOFIL Aquashine and REVOFIL Aquashine BR

Dermal / Epidermal cohesive effect:+ 75% Collagen 1, + 48% Hyaluronic acid

Direct Inhibition of Hyaluronidase Activity:- 91% Inhibition

Protection of Photo-induced cell damage:+ 60% Protection